Work

Results of PAC203: A Randomized Phase 2 Dose-Finding Study and Determination of the Recommended Dose of Pacritinib

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-129293

Authors: Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklos Egyed, Claire N Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jennifer O'Sullivan, Sarah A Buckley, Diane R. Mould, Shanthakumar Tyavanagimatt, Jennifer A. Smith, John Mascarenhas

Institutions: Cleveland Clinic, Vanderbilt University Medical Center, Fred Hutch Cancer Center, University of Michigan, Somogy Megyei Kaposi Mór Oktató Kórház, National Health Service, Guy's and St Thomas' NHS Foundation Trust, University of Kansas Medical Center, University of Florence, University of Oxford, CTI BioPharma (United States), Phoenix Bioinformatics, Phoenix Medical Research, Panorama Research (United States), Phoenix Geophysics (Canada), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990530712

Cites:

Cited by: 23

Related to: 10